An important moment in the history of research at Emory University occurred last week when a ribbon-cutting ceremony was held for the new Health Sciences Research Building II. The new eight-story, 350,000-square-foot building will house more than 1,000 researchers from across a variety of specialties including: Winship Cancer Institute, pediatrics, biomedical engineering, cardiovascular medicine, the Emory Vaccine Center, radiology and brain health.
Supported by a $6 million, three-year grant from the Robert W. Woodruff Foundation, researchers from the American Cancer Society and Winship are building a cloud-based technical infrastructure that aims to significantly accelerate cancer research and improve patient outcomes in Georgia.
Winship and Emory University School of Medicine mourn the loss of an esteemed cancer researcher and beloved member of the Emory community, Brian Michael Olson, PhD. Olson was a member of Winship’s Cancer Immunology Research Program and assistant professor in the Department of Hematology and Medical Oncology.
Winship members Anant Madabhushi, PhD, Cassandra Quave, PhD, and David Prologo, MD, are recipients of the Emory Office of Technology Transfer’s Corporate Partnership of the Year, EmpoHER and Start-Up of the Year awards, respectively. This year’s awardees will be celebrated during an event on March 23.
In a brief for the American College of Surgeons, Winship gynecologic oncologist Susan C. Modesitt, MD, discusses how surgeons can reduce the impact of ovarian cancer by promoting opportunistic salpingectomies, (the removal of fallopian tubes) among patients who have completed childbearing and are undergoing other pelvic surgeries.
In a recent episode of the Healthcare Unfiltered podcast, Winship advanced practice providers (APPs) Kathryn Simon, MMSc, PA-C, and Sarah Wyman, MSN, ACNP-BC, discuss the impact and contributions APPs make to oncology care in the era of precision medicine.
Members of the Winship community gathered on March 14 for an in-person and virtual town hall meeting. View a recording of the Winship Town Hall, which included updates on clinical and research advances, new research partnerships and progress on the new Winship at Emory Midtown cancer care center opening this May.
In preparation for the opening of Winship at Emory Midtown, volunteers will help assemble and test electronic badges for the Real Time Location System at the new facility on March 21 from 9 to 5 p.m. The badges use innovative location tracking technology to decrease wait times and increase efficiency as patients are seen in the clinic.
Below are four selected Winship publications out of 56 published over the past week:
Issa GC, Aldoss I, DiPersio J, Cuglievan B, Stone R, Arellano M, Thirman MJ, Patel MR, Dickens DS, Shenoy S, Shukla N, Kantarjian H, Armstrong SA, Perner F, Perry JA, Rosen G, Bagley RG, Meyers ML, Ordentlich P, Gu Y, Kumar V, Smith S, McGeehan GM, Stein EM. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.Nature. 2023; PubMed PMID: 36922593.
Shah SB, Carlson CR, Lai K, Zhong Z, Marsico G, Lee KM, Félix Vélez NE, Abeles EB, Allam M, Hu T, Walter LD, Martin KE, Gandhi K, Butler SD, Puri R, McCleary-Wheeler AL, Tam W, Elemento O, Takata K, Steidl C, Scott DW, Fontan L, Ueno H, Cosgrove BD, Inghirami G, García AJ, Coskun AF, Koff JL, Melnick A, Singh A. Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas.Nature Materials. 2023; PubMed PMID: 36928381.
Have a story for Winship Weekly? Submit your news here.
About Winship Cancer Institute of Emory University The coordinating center for cancer research, education and care throughout Emory University and Emory Healthcare, Winship Cancer Institute of Emory University is Georgia’s only National Cancer Institute-designated Comprehensive Cancer Center, a prestigious distinction given only to the top 3% of cancer centers nationwide for conducting cancer research, and providing training, that is transforming cancer care, prevention, detection and survivorship.